In the present study, in vitro and in vivo experiments showed that overexpression of TP53INP1 significantly reversed the promoting effects of miR-106a in the metastatic steps of lung adenocarcinoma, including cell migration, intravasation into the surrounding circulatory system (via EMT) and cell survival. The gene discussed is TP53INP1; the disease is lung adenocarcinoma.